COMMON MAPS
Map version new-york activity top-down
Main site Contact
Menu
↑ parent activity group ·
research dossier

REASON FOR HOPE INC
NEW YORK, NY · EIN 872435191 · Form 990 · FY2024 · NTEE F01 · Mental Health & Crisis Intervention · Medium ($1M-$10M) · reason-for-hope.org
revenue
$1.3M
expenses
$1.1M
net assets
$861K
employees
3
program ratio
91%
mission · from form 990

REASON FOR HOPE, INC.'S MISSION IS TO PREVENT DEATHS OF DESPAIR BY HELPING TO DEVELOP AND ADVOCATE FOR THE POLICY AND LEGAL REFORMS NEEDED TO FACILITATE SAFE AND AFFORDABLE ACCESS TO PSYCHEDELIC AND OTHER EMERGING THERAPIES FOR THE TREATMENT OF VARIOUS MENTAL HEALTH CONDITIONS.

profile · synthesized from sources

Reason for Hope Inc. is a nonprofit focused on preventing deaths of despair by advancing access to psychedelic and emerging mental health therapies. The organization supports clinical research, public and policy education, and advocacy for regulatory and legal reforms, with a strong emphasis on veterans and equitable access. It operates nationally, partnering with state and federal entities to influence policy and fund evidence generation.

irs program accomplishments · form 990 part iii · fy2024

What they reported doing

  1. #1 primary $190K
    GRANT FUNDING: PROVIDES FUNDING TO VETERAN MENTAL HEALTH LEADERSHIP COALITION FOR EDUCATION OF VETERAN COMMUNITY ON PSYCHEDELIC AND OTHER EMERGING THERAPIES FOR VETERANS, COMMUNITY ORGANIZING AND EVENTS, CONSENSUS POLICY DEVELOPMENT, AND ADVOCACY.
named programs · 4 · from sources

What they call their work

MDMA-Assisted Group Therapy Clinical Study for Veterans with PTSD
Co-funded clinical trial with the State of Maryland evaluating group vs. individual MDMA-assisted therapy protocols for veterans with PTSD to assess scalability and cost-effectiveness.
Supporting ARPA-H EVIDENT Initiative
Support for a $100 million ARPA-H initiative to study rapid-acting mental health interventions and develop objective diagnostics, with a focus on veterans.
Supporting the Freedom to Heal Act
Advocacy initiative to amend Right to Try laws, enabling patients with terminal or life-threatening conditions to access investigational psychedelic therapies despite Schedule 1 restrictions.
Supporting the VHA Novel Therapeutics Preparedness Act
Policy advocacy to ensure the Department of Veterans Affairs is equipped to implement emerging mental health treatments, including psychedelic-assisted therapies, as they gain FDA approval.
activities · 2 groups

What they do

  • Mental Health Research and Services Funding 2 activities
    • Funding delivery of psychedelic-assisted therapies for veterans in crisis
      Provides financial support to organizations that deliver psychedelic-assisted therapy treatments to veterans in crisis.
    • Funding mental health advocacy and policy development for veterans
      Funds the Veteran Mental Health Leadership Coalition to educate veterans on psychedelic and emerging therapies, organize community events, and support policy advocacy and consensus development.
  • Psychedelic Therapy Support & Advocacy 1 activity
    • Funding clinical research on emerging mental health therapies
      Has contributed over $1.5 million to support clinical research and trials on emerging mental health treatments, including funding an MDMA-assisted therapy trial for veterans with PTSD at Sunstone Therapies in partnership with the State of Maryland.
financials · form 990 · fy2024
revenue
Total revenue$1.28M
Contributions & grants$1.26M99%
Program service revenue$00%
Investment income$16K1%
Other revenue$0
expenses
Total expenses$1.12M
Program expenses91%
Admin / overhead4%
Fundraising4%
Salaries & benefits$584K
Grants paid out$190K
Largest expense lineCompensation
balance sheet
Total assets$895K
Cash$895K
Investments$0
Liabilities$34K
Net assets$861K
Liquid reserves9.6 mo
3 years on record · 2022–2024 · YoY revenue +8.3%
leadership · form 990 part vii · fy2024

Who runs it

paid leadership · 3
NameTitleHours/wkCompensation
BRETT M WATERS EXECUTIVE DIRECTOR 70 $250K
JESSE MACLACHLAN DIRECTOR OF STATE POLICY 45 $120K
MARTIN R STEELE CHIEF EXECUTIVE OFFICER 20 $120K
board members · 2
  • HALEY WATERS — DIRECTOR
  • JULIE WATERS — DIRECTOR
relationships · 3

Who they work with

  • State of Maryland Partner — Co-funding a clinical trial on MDMA-assisted therapy for veterans with PTSD.
  • Sunstone Therapies Partner — Conducting a clinical trial on MDMA-assisted therapy for veterans with PTSD, co-funded by Reason for Hope.
  • Veteran Mental Health Leadership Coalition Partner — Receives grant funding from Reason for Hope Inc to support education, community organizing, and advocacy efforts related to psychedelic and emerging therapies for veterans.
strategies · 2

How they approach the work

Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.

  • Policy and Legal Reform Advocacy
    methodology: policy_and_legal_reform_advocacy
    By advocating for changes in laws and regulations, we enable safe and affordable access to psychedelic and other emerging mental health therapies, because systemic barriers are a primary obstacle to scaling effective treatments and preventing deaths of despair.
  • Real-World Evidence Generation for Clinical Adoption
    methodology: real_world_evidence_generation
    By generating clinical evidence from real-world patient populations and cost-effective care models, we increase the likelihood of insurance coverage for emerging mental health therapies, because payer reimbursement is a critical gateway to broad access and sustainable integration into mainstream care.